I’m often sloth-like when it comes to selling positions
in good companies, but it looks to me like the time to part company with
H. Lundbeck A/S (OTCPK:HLUYY) (LUN.CO)
may be close at hand. Despite concerted efforts to differentiate its
new product portfolio, Lundbeck is struggling to gain much headway
versus generics in the U.S., while generic competition continues to
threaten lucrative profit centers in the mature portfolio. What’s more,
the cupboards are pretty bare when it comes to the pipeline, and though
management seems more positive on M&A than it has in the past,
early-stage assets aren’t likely to garner much enthusiasm.
Lundbeck
shares are trading around my fair value, suggesting a total return
potential in the high-single digits – which really isn’t too bad today
(and part of the reason I’ve been slow to sell). The announcement of a
new CEO could also be a stock-moving event (in either direction), as he
or she will likely have a vision for Lundbeck that offers at least some
change from today. I don’t believe my low single-digit growth
expectations are all that aggressive, but these shares are looking
pretty “meh” after a strong run driven by new launches and rigorous cost
restructuring.
Continue here:
Lundbeck Looks Largely Played Out
No comments:
Post a Comment